Updated Covid vaccine has 54% effectiveness, new data suggest
New data released Thursday by the CDC suggest that the most recent Covid-19 booster offers about 54% percent protection against infection with the virus.
New data released Thursday by the CDC suggest that the most recent Covid-19 booster offers about 54% percent protection against infection with the virus.
Despite advances in therapy options, pulmonary embolism (PE) continues to carry a high risk of mortality and morbidity. Currently, therapeutic options are limited with only…
Download STAT’s e-book to explore the challenges and steps to improve care for an aging population.
A new report suggests that the Texas man who wasinfected with bird flu virus may be the first detected case H5N1 transmitting from a mammal…
Background Elevated heart rate (HR) predicts cardiovascular disease and mortality, but there are no established normal limits for ambulatory HR. We used data from the…
UC San Diego Continuing Professional Development, Precision Cardiovascular Care Symposium: Transitioning Care from Phenotypes to Genotypes – NO CME, 5/3/2024 7:00:00 AM – 5/3/2024 7:00:00…
Introduction: Blood lipoprotein(a) (Lp(a)) levels have been observed to be inversely correlated with type 2 diabetes (T2D). In this Mendelian Randomization (MR) study, the causal…
On May 8, join us for a conversation with practicing neurologists about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new…
Center for Health and Nature and Department of Cardiology, Houston Methodist Hospital, TX (K.N., S.A.-K.). Correspondence to: Sadeer Al-Kindi, MD, FACC, Center for Health and…
Amgen said it’s “very encouraged” by interim Phase 2 data for its obesity drug, quickly sparking investor interest. Here are the burning questions surrounding Amgen’s…
A virtual-second model can have long-term benefits across the health care system, from improving patients’ experiences to growing the telehealth market.